vs
NexPoint Real Estate Finance, Inc.（NREF）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
TriSalus Life Sciences, Inc.的季度营收约是NexPoint Real Estate Finance, Inc.的1.2倍（$13.2M vs $11.1M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -73.9%，领先290.5%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs -48.8%）
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
NREF vs TLSI — 直观对比
营收规模更大
TLSI
是对方的1.2倍
$11.1M
营收增速更快
TLSI
高出108.7%
-48.8%
净利率更高
NREF
高出290.5%
-73.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $13.2M |
| 净利润 | $24.0M | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | — | -24.8% |
| 净利率 | 216.6% | -73.9% |
| 营收同比 | -48.8% | 59.8% |
| 净利润同比 | 58.7% | 3.5% |
| 每股收益（稀释后） | $0.47 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NREFTLSI
| Q4 25 | $11.1M | $13.2M | ||
| Q3 25 | $12.5M | $11.6M | ||
| Q2 25 | $12.1M | $11.2M | ||
| Q1 25 | $11.5M | $9.2M | ||
| Q4 24 | $21.7M | $8.3M | ||
| Q3 24 | $12.5M | $7.3M | ||
| Q2 24 | $6.7M | $7.4M | ||
| Q1 24 | $-12.8M | $6.5M |
净利润NREFTLSI
| Q4 25 | $24.0M | $-9.8M | ||
| Q3 25 | $50.9M | $-10.8M | ||
| Q2 25 | $22.3M | $-8.3M | ||
| Q1 25 | $26.0M | $-10.4M | ||
| Q4 24 | $15.2M | $-10.1M | ||
| Q3 24 | $23.3M | $-2.4M | ||
| Q2 24 | $12.1M | $-4.3M | ||
| Q1 24 | $-14.6M | $-13.2M |
毛利率NREFTLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率NREFTLSI
| Q4 25 | — | -24.8% | ||
| Q3 25 | — | -77.9% | ||
| Q2 25 | — | -65.4% | ||
| Q1 25 | — | -79.9% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | — | -118.9% | ||
| Q2 24 | — | -111.0% | ||
| Q1 24 | — | -180.8% |
净利率NREFTLSI
| Q4 25 | 216.6% | -73.9% | ||
| Q3 25 | 407.0% | -93.5% | ||
| Q2 25 | 184.5% | -73.9% | ||
| Q1 25 | 225.6% | -113.2% | ||
| Q4 24 | 69.9% | -122.4% | ||
| Q3 24 | 186.4% | -32.6% | ||
| Q2 24 | 179.7% | -58.8% | ||
| Q1 24 | 114.3% | -204.5% |
每股收益（稀释后）NREFTLSI
| Q4 25 | $0.47 | $-0.22 | ||
| Q3 25 | $1.14 | $-0.96 | ||
| Q2 25 | $0.54 | $-0.27 | ||
| Q1 25 | $0.70 | $-0.39 | ||
| Q4 24 | $0.71 | $-0.38 | ||
| Q3 24 | $0.74 | $-0.12 | ||
| Q2 24 | $0.40 | $-0.21 | ||
| Q1 24 | $-0.83 | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.1M | $20.4M |
| 总债务越低越好 | $771.2M | — |
| 股东权益账面价值 | $388.0M | $-33.9M |
| 总资产 | $5.3B | $35.3M |
| 负债/权益比越低杠杆越低 | 1.99× | — |
8季度趋势，按日历期对齐
现金及短期投资NREFTLSI
| Q4 25 | $31.1M | $20.4M | ||
| Q3 25 | $17.9M | $22.7M | ||
| Q2 25 | $9.1M | $26.5M | ||
| Q1 25 | $19.2M | $13.0M | ||
| Q4 24 | $3.9M | $8.5M | ||
| Q3 24 | $34.7M | $11.3M | ||
| Q2 24 | $4.3M | $16.5M | ||
| Q1 24 | $13.5M | $4.0M |
总债务NREFTLSI
| Q4 25 | $771.2M | — | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | — | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
股东权益NREFTLSI
| Q4 25 | $388.0M | $-33.9M | ||
| Q3 25 | $375.4M | $-26.7M | ||
| Q2 25 | $348.2M | $-19.4M | ||
| Q1 25 | $343.7M | $-34.4M | ||
| Q4 24 | $336.5M | $-25.9M | ||
| Q3 24 | $335.8M | $-20.4M | ||
| Q2 24 | $327.5M | $-25.3M | ||
| Q1 24 | $327.1M | $-36.0M |
总资产NREFTLSI
| Q4 25 | $5.3B | $35.3M | ||
| Q3 25 | $5.3B | $36.5M | ||
| Q2 25 | $5.4B | $41.3M | ||
| Q1 25 | $5.4B | $28.6M | ||
| Q4 24 | $5.4B | $24.0M | ||
| Q3 24 | $5.7B | $27.5M | ||
| Q2 24 | $6.6B | $32.4M | ||
| Q1 24 | $7.1B | $17.9M |
负债/权益比NREFTLSI
| Q4 25 | 1.99× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.5M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流NREFTLSI
| Q4 25 | $-4.5M | $-2.5M | ||
| Q3 25 | $8.1M | $-3.7M | ||
| Q2 25 | $3.3M | $-7.3M | ||
| Q1 25 | $16.0M | $-4.5M | ||
| Q4 24 | $4.4M | $-5.7M | ||
| Q3 24 | $14.7M | $-10.8M | ||
| Q2 24 | $-7.5M | $-13.4M | ||
| Q1 24 | $17.7M | $-10.9M |
自由现金流NREFTLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率NREFTLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度NREFTLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
现金转化率NREFTLSI
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
